185 related articles for article (PubMed ID: 26239453)
1. Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy.
Gourier HC; Chong NV
J Clin Med; 2015 May; 4(5):874-83. PubMed ID: 26239453
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
Fariss RN; Apte SS; Luthert PJ; Bird AC; Milam AH
Br J Ophthalmol; 1998 Nov; 82(11):1329-34. PubMed ID: 9924344
[TBL] [Abstract][Full Text] [Related]
3. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
[TBL] [Abstract][Full Text] [Related]
4. Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter.
Weber BH; Vogt G; Wolz W; Ives EJ; Ewing CC
Nat Genet; 1994 Jun; 7(2):158-61. PubMed ID: 7920634
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.
Knupp C; Chong NH; Munro PM; Luthert PJ; Squire JM
J Struct Biol; 2002; 137(1-2):31-40. PubMed ID: 12064931
[TBL] [Abstract][Full Text] [Related]
6. Sorsby's fundus dystrophy: what does TIMP3 tell us about general mechanisms underlying macular degeneration?
Tymms MJ
Clin Exp Optom; 1999; 82(4):124-129. PubMed ID: 12482286
[TBL] [Abstract][Full Text] [Related]
7. Sorsby's fundus dystrophy. A clinical study.
Polkinghorne PJ; Capon MR; Berninger T; Lyness AL; Sehmi K; Bird AC
Ophthalmology; 1989 Dec; 96(12):1763-8. PubMed ID: 2622621
[TBL] [Abstract][Full Text] [Related]
8. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.
Qi JH; Ebrahem Q; Yeow K; Edwards DR; Fox PL; Anand-Apte B
J Biol Chem; 2002 Apr; 277(16):13394-400. PubMed ID: 11821400
[TBL] [Abstract][Full Text] [Related]
9. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
Li Z; Clarke MP; Barker MD; McKie N
Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism.
Clarke M; Mitchell KW; Goodship J; McDonnell S; Barker MD; Griffiths ID; McKie N
Br J Ophthalmol; 2001 Dec; 85(12):1429-31. PubMed ID: 11734514
[TBL] [Abstract][Full Text] [Related]
11. Sorsby's fundus dystrophy. A light and electron microscopic study.
Capon MR; Marshall J; Krafft JI; Alexander RA; Hiscott PS; Bird AC
Ophthalmology; 1989 Dec; 96(12):1769-77. PubMed ID: 2482957
[TBL] [Abstract][Full Text] [Related]
12. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes.
Spraul CW; Lang GE; Grossniklaus HE; Lang GK
Surv Ophthalmol; 1999 Oct; 44 Suppl 1():S10-32. PubMed ID: 10548114
[TBL] [Abstract][Full Text] [Related]
13. [Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].
Copete-Piqueras S; Cava-Valenciano C; Flores-Moreno I; Moreno-Valladares A; Bautista Ruescas V
Arch Soc Esp Oftalmol; 2013 Jun; 88(6):240-3. PubMed ID: 23726310
[TBL] [Abstract][Full Text] [Related]
14. The dynamic nature of Bruch's membrane.
Booij JC; Baas DC; Beisekeeva J; Gorgels TG; Bergen AA
Prog Retin Eye Res; 2010 Jan; 29(1):1-18. PubMed ID: 19747980
[TBL] [Abstract][Full Text] [Related]
15. Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation.
Sieving PA; Boskovich S; Bingham E; Pawar H
Trans Am Ophthalmol Soc; 1996; 94():275-94; discussion 295-7. PubMed ID: 8981701
[TBL] [Abstract][Full Text] [Related]
16. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
Langton KP; McKie N; Smith BM; Brown NJ; Barker MD
Hum Mol Genet; 2005 Dec; 14(23):3579-86. PubMed ID: 16223891
[TBL] [Abstract][Full Text] [Related]
17. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
[TBL] [Abstract][Full Text] [Related]
18. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.
Majid MA; Smith VA; Matthews FJ; Newby AC; Dick AD
Br J Ophthalmol; 2006 Oct; 90(10):1310-5. PubMed ID: 16837541
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye.
Fariss RN; Apte SS; Olsen BR; Iwata K; Milam AH
Am J Pathol; 1997 Jan; 150(1):323-8. PubMed ID: 9006347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
